Netherlands· NL-a7b5e020410c
Vasotec 16 mg/5 mg/20 mg, tabletten
A atorvastatin, amlodipin und candesartan product containing amlodipinebesilaat + atorvastatine calcium 3-water + candesartancilexetil, registered in Netherlands by Medcor Pharmaceuticals B.V..
Checked against CBG-MEB (Netherlands) on
Informational only — not a medical device.
The record
At a glance
CBG-MEB (Netherlands)- Active substance
- AMLODIPINEBESILAAT + ATORVASTATINE CALCIUM 3-WATER + CANDESARTANCILEXETIL
- Manufacturer
- Medcor Pharmaceuticals B.V.
- Country
- Netherlands (NL)
- ATC code
- C10BX19
- ATC class
- Atorvastatin, Amlodipin und Candesartan
- Reimbursed
- Not published by this register
- Source register
- CBG-MEB (Netherlands)
- Last checked
- September 29, 2026
Packs & prices · 1
- cbg_meb_id136383//130580
Regulatory notes
No shortage, Orange Book or US label notes for this record.
Same class
Other records under C10BX19
Atorvastatin, amlodipin und candesartan, as other registers publish it.
- NetherlandsVasotec 16 mg/10 mg/20 mg, tablettenMedcor Pharmaceuticals B.V.
- NetherlandsVasotec 16 mg/10 mg/20 mg, tablettenTecnifar Industria Tecnica Farmaceutica S.A.
- NetherlandsVasotec 16 mg/10 mg/40 mg, tablettenTecnifar Industria Tecnica Farmaceutica S.A.
- NetherlandsVasotec 16 mg/5 mg/20 mg, tablettenTecnifar Industria Tecnica Farmaceutica S.A.
- NetherlandsVasotec 16 mg/5 mg/40 mg, tablettenTecnifar Industria Tecnica Farmaceutica S.A.
- NetherlandsVasotec 16 mg/5 mg/40 mg, tablettenMedcor Pharmaceuticals B.V.
Sourced from a public register and reproduced with attribution. Drug Database is not affiliated with, endorsed by, or a partner of CBG-MEB (Netherlands). This is an informational data service and not a medical device — verify against the official source of record before any clinical decision.
For developers
The same record over the API, and the raw payload
GET /v1/drugs/7699ce4a-a53f-4395-b48e-57989dfabbc7 GET /v1/drugs/7699ce4a-a53f-4395-b48e-57989dfabbc7?format=fhir
Every response carries last_synced_at, so freshness is a field rather than a promise. Below is exactly what the ingestion wrote, before any presentation — the same JSON the API returns under payload.
{
"form": "Tablet",
"route": "Oraal gebruik",
"soort": "RVG",
"source": "cbg_meb",
"smpc_url": "https://www.geneesmiddeleninformatiebank.nl/smpc/h130580_smpc.pdf",
"strength": null,
"atc_label": "Atorvastatin, Amlodipine and Candesartan",
"detail_url": "https://www.geneesmiddeleninformatiebank.nl/nl/rvg136383",
"excipients": [
"CALCIUMCARBONAAT (E 170)",
"CARMELLOSE CALCIUM (E 466)",
"CELLULOSE, MICROKRISTALLIJN (E 460(i))",
"CROSCARMELLOSE NATRIUM (E 468)",
"HYPROLOSE (E 463)",
"MACROGOL 8000",
"MAGNESIUMSTEARAAT (E 470b)",
"MANNITOL (D-) (E 421)",
"POLYSORBAAT 80 (E 433)",
"ZETMEEL, GEPREGELATINEERD"
],
"substances": [
"AMLODIPINEBESILAAT",
"ATORVASTATINE CALCIUM 3-WATER",
"CANDESARTANCILEXETIL"
],
"leaflet_url": "https://www.geneesmiddeleninformatiebank.nl/bijsluiters/h136383.pdf",
"authorised_at": "2026/02/25",
"procedure_number": null,
"dispensing_status": "Uitsluitend recept",
"registration_number": "136383//130580",
"additional_monitoring": "N"
}See everything about atorvastatin, amlodipin und candesartan.
This page is the registration. A free account adds the label text as the regulator wrote it, what it costs per daily dose across the markets that publish a price, a feed of what changes in the registers, and an assistant that answers with its sources. Interaction severity is free; mechanism and management are on the Growth plan. No card, nothing to install.